跳至主要内容
临床试验/NCT00745043
NCT00745043已完成不适用

Do Beta-blockers Affect the Use of Beta-agonist Inhalers in COPD?

Waikato Hospital1 个研究点 分布在 1 个国家目标入组 11 人开始时间: 2005年5月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
11
试验地点
1
主要终点
Incremental Shuttle Walk Test Result after taking beta-blockers

研究概览

简要总结

Smoking causes both smoking related lung disease (COPD) and ischaemic heart disease. These are very common conditions and many patients have both diseases. Beta-blocker drugs are extensively used in the treatment of angina, high blood pressure and after heart attacks to decrease symptoms and prolong life. Beta-agonists are used in COPD to decrease breathlessness and improve exercise tolerance. It used to be thought that beta-blockers cannot be used in COPD patients as they may make the breathlessness worse, but it has now been established that they can be used safely. Beta-blocker drugs and beta-agonists have 'opposite' effects on the body and the investigators do not know if they can work together or if they would cancel each other out. The investigators also do not know which of the different types of beta-blockers now available are better for COPD patients. This study will investigate what happens to the airways of people taking both of these drugs.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

年龄范围
40 Years 至 100 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Clinical diagnosis of COPD
  • > 40 years of age
  • > 15 pack year smoking history

排除标准

  • Contra-indication to beta-blocker use
  • Severe COPD FEV1 < 30% or 1 L
  • Not responsive the methacholine

研究组 & 干预措施

R302

Placebo Comparator

Daily placebo capsules

干预措施: bronchodilator response (Drug)

R303

Active Comparator

Daily metoprolol 95mg capsules

干预措施: bronchodilator response (Drug)

R304

Active Comparator

Daily propranolol 80mg capsules

干预措施: bronchodilator response (Drug)

Open Label

Active Comparator

Daily Metoprolol 190mg capsules

干预措施: bronchodilator response (Drug)

结局指标

主要结局

Incremental Shuttle Walk Test Result after taking beta-blockers

时间窗: 7-10 days

Bronchodilator response to salbutamol after beta-blockers

时间窗: 7-10 days

次要结局

未报告次要终点

研究者

申办方类型
Other

研究点 (1)

Loading locations...

相似试验

Beta-Blocker in Chronic Obstructive Pulmonary... | 临床试验